Cholesterol Efflux Capacity in Atrial Fibrillation
Corresponding Organization :
Other organizations : Juntendo University, Juntendo University Nerima Hospital, Juntendo University Urayasu Hospital, Japan Agency for Medical Research and Development
Protocol cited in 3 other protocols
Variable analysis
- Presence or absence of cyclic-3',5'-AMP (cAMP) to induce ABCA1 expression
- Global cholesterol efflux capacity (CEC) of HDL
- ABCA1-dependent CEC of HDL
- Non-ABCA1-dependent CEC of HDL
- J774.1 murine macrophage-like cells
- Labeling of cells with [3H]-cholesterol
- Enrichment of cells with free cholesterol using Ac-LDL and ACAT inhibitor
- Equilibration of cells in media with 0.2% BSA and ACAT inhibitor
- Efflux media containing 2.8% apoB-depleted serum
- Pooled control serum collected from healthy volunteers (age range, 27–32 years old, n = 4)
- Pooled control serum collected from healthy volunteers (age range, 27–32 years old, n = 4)
- Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!